|
| Exchange Disseminated Time 22/05/2018 16:52:19 | Gufic Biosciences Ltd has informed BSE that a meeting of the Board of Directors of the Company is scheduled to be held on May 29, 2018, inter alia, to consider and approve the Audited Financial Results of the Company for the quarter and year ended March 31, 2018 and recommend dividend for the financial year 2017-18, if any.
Further, pursuant to the provisions of Securities and Exchange Board of India (Prohibition of Insider Trading) Regulations, 2015 and as per the terms of "Code of Conduct Insider Trading" of the Company, the trading window shall be closed from May 22, 2018 to May 31, 2018 (both days inclusive). The communication has been circulated to all Directors, Officers and
Designated Employees of the Company. |
|
|